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http:WHAT THIS PAPER ADDS
It is becoming more common to treat peripheral arterial diseases endovascularly with bare metal stents (BMS),
often with high success rates. However, complications such as BMS infections do occur and have high morbidity
(17.2e75.3%) and high mortality (32.5%). This study presents a case report of a BMS infection and an extensive
review of literature of all BMS infections (coronary and peripheral) reported up to the present day. This review
gives an insight into the risk factors, signs and symptoms, useful imaging techniques, treatment options, and
(treatment-speciﬁc) mortality.Objective: The objective of the paper is to present a case of an infected bare metal stent in the left common iliac
artery that was removed by an urgent operation, and to review the literature on diagnosis and outcome of
infected coronary and non-coronary metal stents.
Methods: A systematic search of the Medline database was performed with the purpose of identifying risk
factors, signs and symptoms, imaging strategies, and treatment modalities of bare metal stent infections, both
coronary and peripheral.
Results: In total, 76 additional studies/case reports (48 non-coronary; 29 coronary) were included and analyzed.
Intravascular bare metal stent infections are a rare but serious complication, often leading to emergency surgery
(overall: 75.3%; non-coronary cases: 83.3%; coronary cases: 62.1%). In 25.0% of the non-coronary cases, infection
led to amputation of an extremity or removal of viscera. Reported mortality was up to 32.5% of the cases (non-
coronary: 22.9%; coronary 48.3%). Physicians should always be suspicious of a stent infection when patients
present with aspeciﬁc symptoms such as fever and chills after stent placement. Additional imaging can be used to
detect the presence of a pseudoaneurysm. A PET-CT is an ideal medium for identiﬁcation of a stent infection.
Conclusions: Intravascular stent infection is associated with a high risk of morbidity and mortality. Surgery is the
preferred treatment option, but not always possible, especially in patients with a coronary stent. In selected
cases, bare metal stent infections may be prevented by the use of prophylactic antibiotics at stent placement.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Percutaneous transluminal angioplasty (PTA) with bare
metal stent placement has become a very popular treat-
ment modality for stenotic lesions, after being successfully
introduced in humans in 1983.1e3 The success is largely
because of its minimally invasive character, rendering this
an ideal treatment option for patients with multiple
comorbidities. However, a stent infection is a rare compli-
cation with a high morbidity and high mortality, which mayrresponding author. W.M.P.F. Bosman, Department of Surgery, Rijn-
ospital, Postbus 4220, 2350 CC Leiderdorp, The Netherlands.
il address: w.bosman@rijnland.nl (W.M.P.F. Bosman).
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//dx.doi.org/10.1016/j.ejvs.2013.10.006necessitate maximal invasive surgery.4 The current study
consists of a case report of a bare metal stent infection,
which occurred in Rijnland Hospital, Leiderdorp, The
Netherlands, when a stent was placed after prolonged
thrombolysis (48 hours) through the same sheath, and of a
systematic literature search, in which 76 additional cases of
intravascular bare metal stent infections (coronary and
peripheral) were identiﬁed. Risk factors, signs and symp-
toms, useful imaging techniques, treatment options, and
mortality were identiﬁed and reported.
A 50-year-old woman without any signiﬁcant comorbid-
ities was admitted to the emergency department of Rijn-
land Hospital with a cold, pale, and painful left lower leg.
She was woken by an acute onset of the pain, which also
radiated to her back. Physical examination showed a pale
lower leg without palpable pulsations of the dorsalis pedis
Figure 1. Antegrade angiography on presentation on the emer-
gency department showing an occlusion in the left common iliac
artery. A retrograde catheter is placed in the left femoral artery,
through which urokinase is administered.
Figure 2. Control angiography at 24 hours of thrombolysis. The left
common iliac artery is 60% patent and the thrombolysis is
continued for another 24 hours.
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over the popliteal and femoral artery, and capillary reﬁll was
prolonged (6 seconds). The patient was clinically diagnosed
with an acute arterial occlusion and an angiogram was
performed through a contralateral puncture in the right
groin. It showed an occlusion of the left common iliac artery
(CIA) reaching to the iliac bifurcation and a thrombus in
external iliac artery (Fig. 1). The popliteal artery was
occluded by an embolus. The crural arteries were not
visualized. Subsequently, a 6 Fr sheath was placed in a
retrograde fashion in the left common femoral artery to
recanalize the occlusion in the CIA and urokinase treatment
was started (bolus 100.000 IE and continuous infusion
100.000 IE/h). The urokinase was sprayed in the thrombus
through a valved infusion catheter (Cragg-McNamara
Valved Infusion Catheter, EV3, Plymouth, MN, USA). After
24 hours a control angiogram was performed, which
showed a successful recanalization of the occlusion in the
left CIA with a persistent 40% stenosis over 4 cm length and
a minimal embolism remaining in the popliteal artery
(Fig. 2). Thrombolysis was continued for another 24 hours.
Control angiogram, 48 hours after starting the throm-
bolytic therapy, showed a persistent 40% stenosis in the CIA
and a successful thrombolysis of the iliac, popliteal artery
and crural arteries. To prevent a new occlusion, a nitinol
stent (S.M.A.R.T. Control nitinol stent; Cordis Corporation,
Bridgewater, NJ, USA) was placed in the left CIA (Fig. 3).
After the placement of the stent, the sheath was removed
and a pressure bandage was applied for 12 hours accordingto standard hospital protocol. The patient was discharged
from the hospital the day after without any symptoms.
Four weeks later the patient was re-admitted with
symptoms of tenderness in the left buttock and leg, a
warm, slightly swollen left knee, and a fever (T 39 C). On
the ventral side of her leg there were multiple petechiae.
The inguinal area was unremarkable without hematoma or
lymphadenopathy and peripheral pulsations were present.
Her blood analysis showed a CRP of 248 mg/L, a leukocy-
tosis of 14.2  109/L and a BSE of 68 mm/h. A septic
arthritis of the knee was excluded through a synovial
puncture by an orthopedic surgeon. After taking blood
cultures, clinical treatment with intravenous antibiotics
(cefuroxim 750 mg 3dd1, gentamycin 400 mg 1dd1) was
started. During admission the diagnosis of endocarditis was
excluded by a cardiologist via a transthoracic echocardio-
gram. The blood cultures showed Staphylococcus aureus,
after which the antibiotics were changed to ﬂucloxacillin
12g/24h. After a week, a PET-CT was performed which
showed an infected mass around the stent in the left CIA
(Fig. 4A, B), a hydronephrosis of the left kidney caused by
obstruction by the mass and no signs of further infection
elsewhere. A standard CT-angiography (CTA) was per-
formed, which conﬁrmed a pseudoaneurysm with contrast
leakage and the hydronephrosis (Fig. 4C).
Following the diagnosis of the infected stent, the patient
was planned for surgery. The hydronephrosis was treated by
an urologist by placing a double-J ureteral catheter in the
left ureter. During the operation, a femoralefemoral
crossover bypass was created using a rifampicin-coated
Figure 3. Control angiography after 48 hours of thrombolysis again showed a 40% stenosis. A PTA was performed and a nitinol stent was
placed (A), after which the control angiogram showed a patent common iliac artery (B).
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installation of the crossover bypass, the left internal iliac
artery and the left common iliac artery were ligated and the
evidently infected common iliac artery and stent were
excised. The culture of the stent was sterile, probably
because of the long treatment with intravenous antibiotics.
The patient was discharged free of symptoms 1 week
postoperatively. The intravenous antibiotic treatment was
continued at home through a central venous catheter for
another 5 weeks. A control duplex ultrasound showed a
patent crossover bypass 6 weeks postoperatively, labora-
tory results showed a CRP of 3 mg/L, leukocytosis of
7.3  109/L and a BSE of 33 mm/h.
REVIEW OF LITERATURE
Methods
Following this case, a literature search was performed to
identify similar cases of bare metal stent infections. We
decided to include all bare metal stent infections in the
vascular system and not to exclude coronary stents. A
PubMed search was performed (Appendix I), in which we
identiﬁed 1073 articles. A total of 68 articles were selected as
intravascular baremetal stent infections by two independent
investigators based on the abstracts. A further eight cases of
baremetal stent infectionswere identiﬁed from references of
the earlier found articles. As shown in Table 1, we collected
and analyzed 77 cases (29 coronary, 48 non-coronary)
including our own.4e73 We decided to present the data for
the overall group, but also to subdivide into subcategories in
coronary8,15,19,24,31,39,40,43e45,47,48,50,53,54,56e59,61,62,65,67e69,72,73 and non-coronary stents,4e7,9e14,16e18,20e23,25e30,32e
38,41,42,46,49,51,52,55,60,63,64,66,70,71 as a result of important dif-
ferences in patient characteristics (ASA-score), stenting situ-
ation (elective/emergency) and also type of stents (bare
metal/drug eluting) used (Tables 2 and 3).Patient/case characteristics
From the selected case reports information was extracted
about the vessel location in which the stent was placed
and the patient condition (Table 2). Per case an ASA-score
was attributed, for as far as this was possible from the
provided information.74 It should be noted that the sum of
the percentages in the vessel location column exceed
100%, as in some cases stents were placed in more than
one vessel.Risk factors and reasons of infection
The etiology of the infection for each individual case is
complex and cannot always be veriﬁed. Table 4 shows the
several risk factors for bare metal stent infections, according
to the authors of the speciﬁc case reports.
In the present case, we believe that the placement of the
stent through an indwelling sheath, in situ for over 48
hours, without the use of antibiotic prophylaxis, could be
the reason for infection. Very similar cases have been
described before.13,34 Furthermore it should be noted that
in our case the stents were placed in an angiosuite, without
optimal sterility, as, for example, it lacked an airtight
preparation room and lamellar ﬂow. Optimal sterility
Figure 4. Overview of PET scan, 5 weeks after stent placement. (A) Overview showing activity around left iliac artery and hydronephrosis
left. (B) PET scan showing activity around iliac stent. (C) Normal CT scan with contrast showing leakage around the stent/pseudo-aneurysm.
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prevention of primary infection of stents.13,15,16,20e22,26,30,70
It is often believed that sterility is not optimal when a
stent is placed in an emergency setting; however, in 63.6%
of reported cases, the infected stent was placed in an
elective setting (Table 3).Pathophysiology
The exact pathophysiology of stent infections in the human
situation remains unclear. The inﬂammatory processes
consist of stent thrombosis, progressive arterial destruction,
septic embolization, pseudoaneurysm formation, arterial
disruption, and hemorrhage.75 Several animal studies have
been performed towards an enhanced insight.75e77 Angio-
plasty leads to denudation of the endothelial lining of the
vessel, which is aggravated by the metal struts of the stent,
after which the arterial media is exposed to the bare metal
struts. The bare metal stent itself can function as a nidus for
bacterial adherence and colonization, after which seques-
ters of the bacteria may spread in the arterial wall, inducing
inﬂammation, pseudoaneurysm, necrosis, and eventually
rupture. The bare metal stent forms the ideal vector for the
bacteria.18,75e77It is uncertain which process occurs ﬁrst, infection pro-
hibiting incorporation or poor incorporation leading to
infection.75 However, it appears that neointima formation
serves as a protective measure against infection and that
delayed bacterial challenge after arterial wall incorporation
is less likely to result in infection.4 This fact is underlined by
the remarkable increase of reported infected coronary
stents in the last decade: from the 24 coronary stent
infection cases reported since 2003, 16 cases were with
drug eluting stents (Tables 1 and 3).43e
45,53,54,56,57,59,61,62,67e69,72,73 The drugs eluded by the stent
were rapamycine,43 sirolimus,45,53,56,57,61,69 pacli-
taxel,44,53,54,59,72 and everolimus.68 The local inﬂammation,
which leads to neointimal growth (caused by proliferation
of smooth muscle cells), neointimal hyperplasia, and
eventually restenosis, is inhibited by the immunosuppres-
sive effects of the drugs.45,57,59,69 However, this inhibition of
neointimal growth may lead to the fact that metallic stents
remain uncovered intraluminally, forming an ideal nidus for
passing bacteria.59,72 This is underlined as in seven of the 16
cases the infection took place later then the ﬁrst 4 weeks
after stent placement (Table 1).53,54,57,59,61,62,72,73
This relatively high infection rate is a concerning side
effect of drug eluting stents, which cannot be neglected.
Table 1. Overview of review of literature.
Case no. Article Case characteristics Stenting Infection details Treatment and outcome
Author Year ASA-score Vessel Elective
setting?
Type stent Time to
presentation
Organism Treatment Outcome
1 Rees5 1991 Unknown Renal Unknown BMS 9 days Unknown AB IV Survived
2 Quinn6 1992 Unknown Vein Unknown BMS 2 days Unknown None Died
3 Chalmers7 1993 III CIA Yes BMS 7 days S. aureus Surgery Survived
4 Gunther8 1993 III Cx No BMS 4 weeks S. aureus Surgery Died
5 Therasse9 1994 II CIA, EIA Yes BMS 10 days S. aureus and S. epidermidis Surgery Died
6 Mossad10 1994 III CIA, EIA Yes BMS 4 months S. aureus Surgery Survived
7 Liu11 1995 III CIA and aorta Yes BMS 2 days S. aureus Surgery Unknown
8 Guest12 1995 III SCV Yes BMS 24 days S. aureus AB IV Survived
9 Deiparine13 1996 II CIA, EIA, CFA No BMS 9 days S. aureus and E. coli Surgery Survived
10 Gordon14 1996 II Renal Yes BMS 22 days Beta-hemolytic
streptococcus
AB IV Survived
11 Leroy15 1996 III Cx Yes BMS 7 weeks P. aeruginosa Surgery Died
12 Weinberg16 1996 II CIA Yes BMS 2 days S. aureus Surgery Survived
13 Hoffman17 1997 II EIA Yes BMS 7 days S. aureus Surgery Survived
14 Bunt18 1997 III EIA No BMS 22 months S. aureus Surgery Died
15 Bouchart19 1997 III Cx No BMS 4 days P. aeruginosa Surgery Survived
16 McIntyre20 1997 I CIA and aorta Yes BMS 9 days S. aureus Surgery Survived
17 Deitch21 1998 IV Renal No BMS 4 months MRSA Surgery Survived
18 DeMaioribus22 1998 II Renal Yes BMS 14 days S. aureus and
Proteus mirabilis
Surgery Survived
19 Muller23 1998 II CIA Yes BMS 12 days S. aureus Surgery Survived
20 Grewe24 1999 II Cx Yes BMS 3 days S. aureus AB IV Died
21 Sheeran25 1999 III CIA No BMS 2 days S. aureus Surgery Died
22 Schachtrupp26 1999 II CIA Yes BMS 10 days S. aureus Surgery Died
23 Giannoukas27 1999 II SFA, POP Yes BMS 14 days MRSA Surgery Survived
24 Bukhari28 2000 II Renal Yes BMS 6 months Unknown AB IV Died
25 Naddour29 2000 III SCV Yes BMS 20 days S. aureus AB IV Survived
26 Tiesenhausen30 2000 III CIA Yes BMS 4 weeks S. aureus Surgery Died
27 Rensing31 2000 III Cx No BMS 4 days S. aureus AB IV Survived
28 Myles32 2000 III SCA Yes BMS 2 days S. aureus AB IV Survived
29 Myles32 2000 II CIA Yes BMS 4 days S. aureus AB IV Survived
30 Malek33 2000 III SCA Yes BMS 9 days S. aureus Surgery Survived
31 Dosluoglu34 2001 III CIA, EIA Yes BMS 7 months MRSA Surgery Survived
32 Dosluoglu34 2001 II CIV No BMS 4 weeks S. epidermidis Surgery Survived
33 Pruitt35 2002 II SCA Yes BMS 14 days S. aureus Surgery Died
34 McWilliams36 2002 II Renal Yes BMS 20 months CNS Surgery Died
35 Grazziotin37 2002 II Carotid Yes BMS 13 months S. aureus Surgery Survived
36 Walton38 2003 III SFA Yes BMS Many months MRSA Surgery Survived
37 Liu39 2003 IV Cx No BMS 18 days S. aureus,
simulans and capitis
Surgery Survived
38 Bangher40 2003 III Cx Yes BMS 2 weeks Candida and CNS Surgery Survived
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Table 1-continued
Case no. Article Case characteristics Stenting Infection details Treatment and outcome
Author Year ASA-score Vessel Elective
setting?
Type stent Time to
presentation
Organism Treatment Outcome
39 Macheda41 2003 III POP No BMS 22 months S. aureus Surgery Survived
40 Bates42 2005 III SCA Yes BMS 3 months S. aureus Surgery Died
41 Alfonso43 2005 III Cx Yes DES 2 days S. aureus AB IV Died
42 Marcu44 2005 II Cx No DES 90 S. aureus Surgery Survived
43 Singh45 2005 II Cx Yes DES 4 months S. aureus Surgery Survived
44 Sternbergh46 2005 Unknown CIA Yes BMS shortly. S. epidermidis Surgery Survived
45 Hoffman47 2005 IV Cx No BMS 7 days S. aureus AB IV Survived
46 Wu48 2005 IV Cx No BMS 7 months S. aureus Surgery Died
47 Ting49 2006 Unknown SFA Yes BMS 3 years MRSA Surgery Survived
48 Cunha50 2006 III Cx Yes BMS Unknown S. aureus AB IV Survived
49 Liapis51 2006 III EIA No BMS 2 months Mucormycosis Surgery Survived
50 Kappert52 2006 III SVC Yes BMS 6 months S. aureus Surgery Survived
51 Hogg4 2007 Unknown SFA Yes BMS Unknown S. aureus Surgery Survived
52 Hogg4 2007 Unknown SFA Yes BMS 4 months P. aeruginosa Surgery Survived
53 Le53 2007 IV Cx No DES 3 months S. aureus Surgery Died
54 Jang54 2007 IV Cx No DES 4 months S. aureus Surgery Survived
55 Kondo55 2007 II EIA Yes BMS 4 months MRSA Surgery Died
56 Garg56 2007 IV Cx No DES 12 days MRSA AB, unﬁt for surgery Died
57 Kishida57 2007 IV Cx No DES 2 months S. aureus Surgery Survived
58 Salinas58 2007 III Cx Yes BMS 5 months MRSA Surgery Died
59 Gonda59 2007 III Cx Yes DES 11 months MRSA Surgery Survived
60 Chisci60 2009 III SFA Yes BMS 2 months Unknown Surgery Survived
61 Chisci60 2009 III SFA Yes BMS 27 months Unknown Surgery Survived
62 Schoenkerman61 2009 IV Cx No BMS 4 days S. aureus AB, unﬁt for surgery Died
63 Schoenkerman61 2009 III Cx Yes DES 26 months S. aureus Surgery Survived
64 Schoenkerman61 2009 IV Cx No DES 2 weeks MRSA AB, unﬁt for surgery Died
65 Garg62 2009 III Cx Yes DES 8 months MRSA AB, unﬁt for surgery Died
66 Raychaudbhuri63 2009 I Basilar No BMS 2 days Fungus Surgery Survived
67 Stout64 2010 II Renal Yes BMS 8 months MRSA Surgery Survived
68 Wu65 2010 IV Cx No BMS 6 days MRSA Endovascular Survived
69 Desai66 2010 Unknown Carotid Yes BMS 2 years S. agalactiae Surgery Unknown
70 Loke67 2011 IV Cx No DES 1 week S. aureus Surgery Unknown
71 Lim68 2011 IV Cx No DES 4 days MRSA Surgery Died
72 Furtado69 2011 III Cx Yes DES 2 weeks P. aeruginosa Surgery Survived
73 Mlynski70 2011 III CIA and aorta Yes BMS 12 months S. pneumoniae Surgery Survived
74 Tanaka71 2012 II EIA Yes BMS 3 years S. aureus Surgery Survived
75 Del Trigo72 2012 III Cx Yes DES 3 years S. aureus Surgery Died
76 Elieson73 2012 IV Cx No BMS and DES 17 days MRSA AB IV Died
77 Present report 2013 I CIA No BMS 4 weeks S. aureus Surgery Survived
CIA ¼ common iliac artery; Cx ¼ coronary; EIA ¼ external iliac artery; SCV ¼ subclavian vein; CFA ¼ common femoral artery; SFA ¼ superﬁcial femoral artery; POP ¼ popliteal artery;
SCV ¼ subclavian vein; SCA ¼ subclavian artery; CIV ¼ common iliac vein; SVC ¼ superior vena cava; BMS ¼ bare metal stent; DES ¼ drug eluting stents; MRSA ¼ methicillin resistant
Staphylococcus Aureus; CNS ¼ coagulase negative staphylococcus; AB ¼ antibiotics; IV ¼ intravenously.
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Table 3. Details of stenting procedures in review of literature, also
sorted for coronary and non-coronary stents.
Overall
(n ¼ 77)
Non-coronary
(n ¼ 48)
Coronary
(n ¼ 29)
% % %
Stenting procedure
Elective setting 63.6 77.1 41.4
Emergency setting 33.8 18.8 58.6
Bare metal stent 80.5 100.0 48.3
Drug eluting stent 20.8 0.0 55.2
Previous PTA/PTCAs 63.6 58.3 72.4
Previous surgery
in same area
31.2 35.4 24.1
Thrombolysis around
stent placement
9.1 12.5 3.4
Prophylactic antibiotics
Given 13.0 12.5 13.8
Not given 40.3 41.7 37.9
Unknown 46.7 45.8 48.3
Time of indwelling
catheter
<6 hoursa 50.6 45.8 58.6
6e12 hours 0.0 0.0 0.0
12e24 hours 5.2 6.3 3.4
24e48 hours 7.8 10.4 3.4
>48 hours 2.6 2.1 3.4
Unknown 33.8 35.4 31.0
a When the authors described their procedure as “standard” or
“uncomplicated”, we assumed that the catheter was removed with
6 hours of placement.
Table 2. Case distribution.
Overall
(n ¼ 77)
Non-coronary
(n ¼ 48)
Coronary
(n ¼ 29)
% % %
ASA score
ASA I 3.9 6.3 0.0
ASA II 27.3 37.5 10.3
ASA III 41.6 39.6 44.8
ASA IV 18.2 2.1 44.8
ASA unknown 10.4 16.7 0.0
Vessel location
Cerebral artery 1.3 2.1 e
Carotid artery 2.6 4.2 e
Subclavian artery 5.2 8.3 e
Coronary 37.7 e 100.0
Renal artery 9.1 14.6 e
Distal aorta 5.2 8.3 e
Common iliac artery 23.4 37.5 e
External iliac artery 9.1 14.6 e
Femoral artery 10.4 16.7 e
Popliteal artery 2.6 4.2 e
Venous 6.5 10.4 e
ASA-scores and vessel locations were extracted from the case
reports. Percentages in the non-coronary and coronary columns
are percentages of the cases in the subselections. It should be
noted that the sum of the percentages exceed 100% as in some
cases several vessels were stented.
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of DES that are currently implanted worldwide, the problem
may be more common than currently evident and thus
physicians should be cognizant of this potential
complication.59
Clinical presentation
The clinical presentation of a stent infection generally
consists of aspeciﬁc symptoms such as fever, malaise, chills,
leukocytosis and more speciﬁc symptoms such as local pain,
local edema, and local skin symptoms (Table 5). Typical
occurring dermal symptoms are petechiae, rash, cellulitis,
and edema. As many of the symptoms are aspeciﬁc, the
diagnosis is one of exclusion, excluding other possible ori-
gins of bacteremia and fever.4 Very often the diagnosis of an
infected stent is missed in the ﬁrst phase, with a subse-
quent delay in deﬁnitive treatment. The average time to
deﬁnitive treatment of the infected stent was 16.4 days,
and in one case a delay of 180 days was described.30 Pa-
tients were often re-admitted to the clinic, without a clear
focus of the infection.15,29,31,43e45,48,51,57e59,61,62 The
symptoms were frequently mistaken for endocardi-
tis,12,23,25,35,47,69,71 cellulitis,10,27,41,64,72,73 an infected intra-
vascular line/pacemaker lead,21,28,50,53,54 or septic arthritis.4
In our case as well, the ﬁrst differential diagnoses were
endocarditis and septic arthritis. These were excluded after
consultation with a cardiologist and an orthopedic surgeon.
Although the average time to presentation is 161 days, in
most cases (57.5%), the infection presents in the ﬁrst
month after stent placement (Table 5). In ten cases, the
infection presented itself more than a year after stentplacement.18,36,37,41,49,60,61,66,71,72 In six of these late cases,
the infection was probably caused by distal infected ulcera-
tion41,49,60,72 or a fresh surgical wound of a secondary
intervention.18,37 In 50.7% of the reported cases, a delay in
recognition of the stent infection was described. The average
delay of recognition from the ﬁrst symptom occurrence was
34.7 days, of which 1.4 days were patient delay and 33.4
days were doctor delay (Table 5). Patients should receive
clear instructions to return to the clinic when these symp-
toms occur, as very often there is a patient delay, sometimes
as high as 3 weeks.30,70 When a patient does return to the
clinic with aspeciﬁc symptoms such as fever, chills, and
malaise (Table 5), the physicians should be alert for stent-
infection, especially in the ﬁrst month after stent placement.Imaging studies
Several different imaging modalities are used for the diag-
nosis of stent-infection (Table 6). In several cases (18.8%) of
infected peripheral stents, transesophageal echocardio-
grams were performed to exclude diagnosis of endocardi-
tis.10,13,29,32,34,35,41,42,71 The presence of a pseudoaneurysm
is an important radiological sign indicating possible stent
infection. In our review, we found that in 77.9% of the cases
a pseudoaneurysm was described (Table 5). Visualization of
pseudoaneurysms was generally performed with a combi-
nation of ultrasound, and CT(A)s and even angiograms.
Table 4. Summary of risk factors for infection according to the
authors of the case reports.
Risk factors for bare metal stent
infection (according to authors of
the case reports)
Case # (see Table 1)
Patient related
Age/general condition 26, 62, 64, 71, 76
Immunosuppression 49, 53
Diabetes 26, 38, 39, 53, 65
Impaired renal function 26, 53, 58, 65
Coincident bacteremia at
placement of stent
(i.e. pneumonia, infected
ulcer, etc.)
6, 21, 22, 36
Habitus/non-sterile access-site 7, 21
Earlier operations in stented area 60, 61
Procedure related
Procedure sterility (i.e. breaks
in sterile technique, less than
ideal aseptic environment of
angiographic suites, occult
glove perforation, etc.)
9, 11, 12, 16, 17,
18, 22, 26, 73, 77
Repeat puncture of the same
arterial access site causing
needle tract contamination
4, 5, 9, 28, 29, 31,
38, 51, 71, 76
Extensive changing of wires
during procedure
23, 76
Prolonged use or re-use of
indwelling catheter
9, 10, 11, 23, 30,
31, 51, 71, 77
Increased procedure time 23, 41, 76
Puncture site hematoma 10, 28, 29, 31
No AB-prophylaxis 18, 19, 23, 77
Stent-related
Local immunosuppression
caused by DES
41, 43, 53, 54, 56, 57,
59, 63, 64, 65, 71,
72, 75
Post-procedure related/
secondary infection
Other source of coincident
bacteremia (i.e. pneumonia,
ulceration, line sepsis, etc.)
17, 24, 30, 37, 39, 40,
48, 55, 73
Colonization of traumatic
pseudo-aneurysm
3, 35
Longer wires and catheters/
passing wires or catheters
through previously deployed stents
12, 44
Repeated punctures upstream of
stent (i.e. central line, hemodialysis
catheter)
8, 19, 24, 40, 54, 58
The potential sources of infection are stated in the left column,
categorized for patient-related, procedure related, stent-related,
and post-procedure related factors, while in the right column
the cases numbers are noted in which the speciﬁc risk factor
was the reason for infection according to the author of the case.
94 W.M.P.F. Bosman et al.To prove active infection, nuclear imaging such as
WBC-scans4,12,18,25,29,32,34,47,50,57,58,62,67,68 and PET-
scans67,72 can be used. A WBC-scan was performed in 16
cases, of which 10 were true positive, and six were falsenegative (Table 7).18,32,34,47,57 However, in these false
negative cases, other non-invasive imaging modalities used
in the same patients were also inconclusive for the diag-
nosis in four cases.18,34,47,57 For example, in the case
described by Kishida et al., the WBC-scan was performed 1
day after stent-placement, making it difﬁcult to detect the
infection already.57
In our case, the stent infection was proved using a PET-CT
scan (Fig. 4A, B). Use of PET-CT had been described in only
two other cases.67,72 In all three cases, the PET-CT was
successful in identifying the stent-infections; however, the
diagnosis could arguably also have been made with other
imaging modalities performed at the same moment
(Table 7). Nevertheless, we believe the PET-CT is a very
useful tool in diagnosis of an infected stent. In a prospective
cohort study with retrospective analysis, the accuracy of
FDG-PET-CT in detecting vascular prosthetic infections, was
analyzed by Bruggink et al.78 The PET-CT had a superior
sensitivity (93% vs 56%) and speciﬁcity (70% vs 57%) when
compared with CT. These ﬁndings were underlined in the
review article of prosthetic graft infections by Legout et al.79Treatment of infected stent
Infected endovascular stents pose difﬁcult management
problems. Successful conservative treatment with antibi-
otics has been described,12,14,29,31,32,47,50 yet in up to 50.0%
of cases it had a fatal outcome (Table 8).24,28,43,61,62,73 It
should be noted that in four of these fatal cases a surgical
approach was preferred, but the patients were either unﬁt
for surgery, or major surgery was refused by the pa-
tients.28,61,62 When antibiotic therapy is the only treatment
option, prescription of antibiotics such as daptomycin or
rifampicin can be considered, as they diffuse in the po-
tential bioﬁlm of the stent.79,80 Cunha et al. described a
successful treatment of a bacterial endocarditis and coro-
nary stent infection by high-dose daptomycin.50
Similar to infected vascular prosthesis, a surgical
approach is preferred. which consists of total removal of the
infected material and subsequent installation of an extra-
anatomical or in situ bypass, preferably with autologous
material.79,80 Surgical therapy was applied in 18 of the
coronary cases and 40 of the non-coronary cases. Table 8
shows the surgical therapy as it was applied in the
selected cases. The morbidity of the infected (non-coronary)
stents is underlined by the high amputation rate and/or
removal of viscera in 25.0% of patients. In the coronary
group there was a high peri-procedural mortality of 16.7%.
The overall mortality in the surgery group was 27.6%, with
mortality up to 38.9% in the coronary group.
In selected cases an endovascular treatment of the stent
infection was chosen.18,30,56,65 Bunt et al. chose to coil a
pseudoaneurysm with coils, followed by above-knee
amputation.18 Garg et al. sealed a perforation of a
mycotic aneurysm of the LAD, as the patient refused major
surgery.56 Tiesenhausen et al. excluded a pseudoaneurysm
with a covered stent, which eventually became infected as
well, requiring surgical excision.30 Wu et al. treated a
Table 5. Details of infectious event in review of literature, also
sorted for coronary and non-coronary stents.
Overall
(n ¼ 77)
Non-coronary
(n ¼ 48)
Coronary
(n ¼ 29)
Time to readmission
Average time to
readmission (days)
161.4 183.5 125.9
<1 week (%) 24.7 20.0 32.1
1e2 weeks (%) 20.5 24.4 14.3
2 weeks-1 month (%) 12.3 13.3 10.7
1e12 months (%) 31.5 28.9 35.7
>1 year (%) 13.7 17.8 7.1
Delay in recognization 50.7% 42.5% 63.0%
Average delay (days) 34.7 43.4 27.4
Patient delay (days) 1.4 1.9 0.7
Doctor delay (days) 33.4 41.5 26.7
Time to deﬁnitive
treatment after
readmission (days)
16.4 15.4 11.8
Organism
Skin commensal 87.0 79.2 100.0
# Staphylococcus
aureus (%)
76.6 70.8 86.2
# MRSA (%) 19.5 14.6 27.6
# Other skinﬂora (%) 14.3 12.5 17.2
Non-skinﬂora (%) 5.2 8.3 0.0
Non-bacterial
(fungus, etc.) (%)
3.9 4.2 3.4
Unknown (%) 6.5 10.4 0.0
Signs and symptoms
Fever (%) 80.5 72.9 93.1
Chills/rigor (%) 31.2 25.0 41.4
Malaise (%) 42.9 47.9 34.5
Weight loss (%) 2.6 2.1 3.4
Septic shocka (%) 27.3 25.0 31.0
Leukocytosis (%) 49.4 52.1 44.8
Local skin problemsb (%) 31.2 43.8 10.3
Local edema (%) 32.5 41.7 17.2
Local pain (%) 66.2 75.0 51.7
Embolization
(not skin) (%)
5.2 6.3 3.4
Pseudoaneurysm
on imaging (%)
77.9 77.1 79.3
a Symptoms such as tachycardia, hypotension, shock, oligo-/
anuria.
b Symptoms such as rash, petechia, cutaneous embolization,
gangrene, cellulitis.
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and antibiotics.65 However, the mortality rate in these four
cases was 75.0%.18,30,56
The overall mortality, disregarding the type of treat-
ment, of infected bare metal stents is very high: in the
coronary group it was 48.3%, in the non-coronary group it
was 22.9%, leading to an overall mortality of 32.5%. This
underlines the importance of peri-procedural sterility and
early recognition and adequate treatment, when the stent
is infected.Organism and prophylactic antibiotics
The organism responsible for the stent infection was a
commensal skin bacterium in the majority (87.0%) of the
included patients (Tables 1 and 2). In most cases (76.6%),
the organism was Staphylococcus aureus, a part of which
was methicillin resistant (MRSA). The large number of skin-
commensal bacteria infections underlines the theories of
many authors that the infection takes place primarily and
mostly peri-procedurally (Table 4). In 3.9% of the cases
there was a non-bacterial infection: Liapis et al. described a
mucormycosis-infection in a patient receiving immunosup-
pression after kidney-transplantation,51 Bangher et al.
showed a Candida infection in a diabetic patient,40 while
Raychaudhuri et al. found a fungus infection in a non-
immunocompromised 36-year-old after stenting of the
basilar artery.63
As previously stated, peri-procedure sterility is essential in
preventing local skin infection and stent infection. Angio-
suites are becoming comparable with operating rooms, with
air-tight preparation rooms and lamellar ﬂow and strict ste-
rility protocols applied during stent placement.81,82
The use of prophylactic antibiotics remains a much-
discussed topic.4,17,32,83 In only 13.0% of cases was admin-
istration of prophylactic antibiotics described, while in
40.3% of the cases it was clearly stated that antibiotics were
not given. In the 10 patients who received prophylactic
antibiotics, in only three cases had infection taken place in
the ﬁrst month.8,61,69 In the other seven cases, the infection
occurred at a later stage.10,28,36,41,51,53,55 Although only
13.0% of the authors administered prophylactic antibiotics
before stent placement, after having to treat a bare metal
stent infection, 44.2% state in their discussions that they
think there is a role for prophylactic antibiotics (Table 8). In
three cases, the authors state that the lack of prophylactic
antibiotics was the reason for the bare metal stent infection
(Table 4).22,23,27
Following the guidelines of the Society of Interventional
Radiology, there is no indication for prophylactic antibiotics
in case of standard placement of bare metal stents in low-
risk patients.83 The main argument against prophylactic
antibiotics is the large number of patients who would be
treated to prevent bare metal stent infection, which would
only have occurred in a few patients,17,32 and therefore the
question arises of cost-effectiveness.9 However, the major
morbidity, necessitating major surgery, and the high mor-
tality (32.5%) of the infections caused by bare metal stents
may justify the use of prophylactic antibiotics such as
cefazolin as most of the organisms were skin-commensals.
Combining the information we have distilled from the re-
view of literature (Tables 3, 5 and 8), we believe there is
role for prophylactic antibiotics in selected cases: Patients with immune deﬁciencies (high age, chronic
renal impairment, DM, immunosuppressive
medications).17,34,83
 Difﬁcult procedures (i.e. multiple guide-wire exchanges,
long procedure time, access site hematomas).34,40,83
Table 6. Imaging studies used for diagnosis of infected stents.
Imaging used
for diagnosis
Overall
(n ¼ 77)
Non-coronary
(n ¼ 48)
Coronary
(n ¼ 29)
% % %
Transesophageal
echocardiogram
32.5 18.8 55.2
Ultrasound 45.5 45.8 44.8
CT(A) 63.6 77.1 41.4
MRI 9.1 8.3 10.3
Angiography 46.8 39.6 58.6
WBC-SCAN 19.5 16.7 24.1
PET-CT 5.2 4.2 6.9
X-ray 15.6 14.6 17.2
Results state the percentage of cases in which each modality was
used.
Table 8. Overview of treatment of infected stents and the
mortality.
Treatment of infected
stent
Overall
(n ¼ 77)
Non-coronary
(n ¼ 48)
Coronary
(n ¼ 29)
% % %
Emergency surgery 75.3 83.3 62.1
Removal of stents 91.4 90.0 94.4
Extra-anatomical
bypass
31.0 45.0 0.0
Anatomical
bypass
44.8 30.0 77.8
Autologous bypass 41.4 25.0 77.8
Prosthetic
bypass
32.8 47.5 0.0
No bypass 17.2 20.0 11.1
Amputation of
extremity/
removal of viscera
(i.e. below knee
amputation,
nephrectomy,
colostomy as
a result of perforation)
17.2 25.0 0.0
Died during surgery 6.9 2.5 16.7
Endovascular treatment 5.2 4.2 6.9
AB IV alone 20.8 14.6 37.9
Infection related
mortality
32.5 22.9 48.3
% Mortality in
surgery group
27.6 22.5 38.9
% Mortality in
endovascular
treated group
75.0 100.0 50.0
% Mortality in AB
IV only group
50.0 14.3 63.6
AB prophylaxis
96 W.M.P.F. Bosman et al. Stenting of areas that are often re-punctured, for
example hemodialysis catheters.12,83
 Prolonged indwelling catheter (>6 hours), for example
during thrombolysis.33,34,83
 Stenting of surgically difﬁcult to reach areas or vessels
(i.e. coronary, intra-thoracic, or intra-abdominal stents.)
as surgical resection will have large morbidity and
mortality.35
 Known colonization of the patient (pre-procedure nose-
swabs)
The guideline underlines that prophylactic antibiotics
should be administered in cases in which there is a high risk
of infection.83 It remains unclear for how long the prophy-
lactic antibiotics should be administered. Hogg et al. state
that after bare metal stent placement a similar lifelong
regimen to that of prosthetic heart valves, for example,
should be followed. This means administration of prophy-
lactic antibiotics before (dental) surgery, GI endoscopy, or
other procedures that may facilitate bacteremia.4 The ani-
mal study of Hearn et al. underlines the fact that an
endovascular stent can easily be infected secondarily fourTable 7. The “true positive” and “false negative” ﬁndings of the
nuclear imaging modalities, WBC-scan and PET-CT used in several
cases.
WBC-Scan PET-CT
No cases used 16 3
True positive 10 3
Other concurrent non-invasive
imaging negative
5 1
Other concurrent non-invasive
imaging positive
5 2
False negative 6 0
Other concurrent non-invasive
imaging negative
4 0
Other concurrent non-invasive
imaging positive
2 0
Both categories are subdivided for other concurrent non-invasive
imaging modalities (i.e. ultrasound, CT, MRI, X-ray) used in the
same case for detecting the infected stent.
recommendation
Author of case report
recommends AB
prophylaxis
44.2 62.5 13.8
Author of case report
discourages AB
prophylaxis
7.8 10.4 3.4
AB prophylaxis not
discussed
in case report
48.1 27.1 82.8
The results in the subcategories of the emergency surgery are
percentages of the number of patients who underwent surgery
(overall n ¼ 58, non-coronary n ¼ 40, coronary n ¼ 18). The
mortality numbers were a percentage of the overall group and
of the treatment subgroups (surgery, endovascular exclusion, or
only antibiotics).weeks after stent placement.77 However, as stated above,
some studies show that the stents can be infected
secondarily as a result of bacteremia even after more than a
year.18,37,41,49,60,72
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An ever increasing number of endovascular procedures such
as thrombolysis and bare metal stenting are performed in
patients with multiple comorbidities. Although a rare
complication, bare metal vascular stent infection does
occur. Treatments of stent infections are procedures with
very high morbidity and mortality (Tables 1 and 8). There-
fore there is a need for a major effort to reduce the risk of
infection of the foreign materials we place in these patients.
Introduction in an absolute aseptic environment, use of an
aseptic technique, and use of prophylactic antibiotics in
selected patients should be pursued. In the presented case
a bare metal stent was placed through a sheath left in situ
for 48 hours because of thrombolysis, a situation which is
not preferable. If we were confronted with a similar case in
future, we would remove the initial sheath and place a new
sheath under sterile conditions in the contralateral groin
after administering prophylactic antibiotics. The relatively
high number of infections with drug eluting stents is con-
cerning, and needs further investigation.
Medical physicians should always be suspicious of a stent
infection when patients present with aspeciﬁc symptoms
such as fever and chills after stent placement (Table 5), and
use imaging to see if a pseudoaneurysm is present. We
believe a PET-CT is an ideal medium for the identiﬁcation of
a stent infection.
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APPENDIX I. SEARCH STRATEGY LITERATURE SEARCH BARE
METAL STENT INFECTIONS.
("stents"[MeSH Major Topic] OR "stent"[ti] OR "stents"[ti]
OR "stenting"[ti]) AND ("bacterial infections"[MeSH Major
Topic] OR "infection"[ti] OR "infections"[ti] OR "infected"[ti]
OR "complication"[ti] OR "complications"[ti] OR "Aneurysm,
False"[Majr] OR "False aneurysm"[ti] OR "False Aneurysm-
s"[ti] OR "Pseudoaneurysm"[ti] OR "Pseudoaneurysms"[ti]
OR "Prosthesis-Related Infections"[Majr] OR "rupture"[ti]
OR "ruptures"[ti]) AND ("Case Reports"[Publication Type]
OR "case report"[ti] OR "case reports"[ti])
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